Trademark: 78058343
Word
BIOSANTE
Status
Dead
Status Code
710
Status Date
Friday, January 6, 2023
Serial Number
78058343
Registration Number
2585471
Registration Date
Tuesday, June 25, 2002
Mark Type
1000
Filing Date
Friday, April 13, 2001
Published for Opposition
Tuesday, April 2, 2002
Cancellation Date
Friday, January 6, 2023

Trademark Owner History

Classifications
5 PHARMACEUTICAL PRODUCTS, NAMELY, PREPARATIONS IN THE NATURE OF TRANSDERMAL GELS FOR USE IN THE ADMINISTRATION OF HORMONES
In the statement, column 1, before line 1, "BioSante Pharmaceuticals, Inc. (Delaware Corporation), 111 Barclay Blvd., Lincolnshire, IL 60069, by merger" should be inserted.

Trademark Events
Jan 6, 2023
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Jun 25, 2021
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
May 25, 2016
Assignment Of Ownership Not Updated Automatically
Jan 1, 2014
Automatic Update Of Assignment Of Ownership
Dec 23, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 23, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 4, 2012
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Jun 4, 2012
Registered And Renewed (First Renewal - 10 Yrs)
Jun 4, 2012
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Jun 4, 2012
Case Assigned To Post Registration Paralegal
May 22, 2012
Teas Section 8 & 9 Received
Jul 7, 2008
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jul 1, 2008
Assigned To Paralegal
Jun 24, 2008
Teas Section 8 & 15 Received
Sep 14, 2007
Case File In Ticrs
Feb 22, 2007
Teas Change Of Correspondence Received
May 15, 2003
Correction Under Section 7 ¿ Processed
Mar 18, 2003
Sec 7 Request Filed
Mar 18, 2003
Paper Received
Jun 25, 2002
Registered-Principal Register
May 20, 2002
Paper Received
Apr 2, 2002
Published For Opposition
Mar 13, 2002
Notice Of Publication
Dec 6, 2001
Approved For Pub - Principal Register
Nov 8, 2001
Correspondence Received In Law Office
Apr 13, 2001
Correspondence Received In Law Office
Jul 30, 2001
Non-Final Action Mailed
Jul 16, 2001
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24